BiotechTube
Home/RS Oncology/Christine Linnehan-Sununu
CL

Christine Linnehan-Sununu

Communications & Branding

RS Oncology

Therapeutic Areas

Oncology

RS Oncology Pipeline

DrugIndicationPhase
RSO-021Malignant Pleural Mesothelioma, Metastatic Breast Cancer, Metastatic Ovarian Cancer, Non-Small Cell Lung CancerPhase 2

Leadership Team at RS Oncology

JD
Jarrett Duncan
Chief Executive Officer
BC
Brian Cunniff, PhD
Chief Science Officer
NP
Nichole Pfeiffer Hicks
Patient Advocacy Liaison & Strategic Partnerships
DF
Dean Fennell, MRCP, FRCP
Clinical Advisory Board Director
View full RS Oncology profile